|
Research update: Gerresheimer AG September 21, 2011 Large outperformance in weak markets Gerresheimer is a well managed, leading specialty glass manufacturer with strong free cash flow. The group has shown solid earnings growth and the shares have proven very ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG March 15, 2011 Steady first quarter 2011 results expected First quarter 2011 results are expected to be released on 7 April 2011. After a record 2010, these could show further steady progress for Germany’s leading specialty glass group. Healthcare and pharmaceutical containers could show ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG October 06, 2010 Sound third quarter 2010 results Germany’s leading specialty glass group, focused on healthcare and pharmaceutical customers, has reported solid third quarter results to August 2010. Sales grew by ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG April 15, 2010 Solid Q1 2010 results –full year forecast confirmed Gerresheimer reported first quarter to February 2010 underlying sales rose marginally to €225m. Net profits reached €2.4m against a ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG August 04, 2009 Steady prospects with low medium-tern risks The leading manufacturer of high-quality primary glass and plastics packaging has some 65% of sales to the health care industry. Other products are focused on ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG April 06, 2009 Sound health care related supplier The primary glass and plastics packaging producer for the pharmaceutical and health care industries reported steady first quarter results. Gerresheimer reiterated its forecast for an underlying 7% sales growth and more than ... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG October 15, 2008 Solid results and maintained forecasts Gerresheimer manufactures high quality primary glass and plastics packaging for the health care industry. Around 65% of sales are for pharmaceutical applications which require approval from drug regulators. Other products include syringes, ampoules and inhalers as well as... ...Subscribe to VISCARDI Research... |
|
Research update: Gerresheimer AG August 22, 2008 Low-risk health care industry Gerresheimer confirmed full year 2008 guidance at the time of its second quarter results. These had shown sales up by 12.8% to €276m and adjusted net profits had nearly tripled to €17.6m. Full year sales growth of some 15% is expected before currency and disposal... ...Subscribe to VISCARDI Research... |
|
Initiation of Coverage: Gerresheimer AG December 18, 2007 Pharma-related, but no drug risks Gerresheimer is a leading international producer of glass and specialist plastic systems primarily for the pharmaceutical and health care industries. Niche products include syringes, ampoules and inhalers. Residual non-core activities are planned for disposal. Re-listed in 2007. Gerresheimer Glas was a majority owned subsidiary... ...Subscribe to VISCARDI Research... |

